title: Acute morphine intoxication during high-dose recombinant interleukin-2 treatment for metastatic renal cell cancer.
authors.forename: R
authors.initials: R
authors.lastname: Bortolussi
authors.forename: F
authors.initials: F
authors.lastname: Fabiani
authors.forename: F
authors.initials: F
authors.lastname: Savron
authors.forename: V
authors.initials: V
authors.lastname: Testa
authors.forename: R
authors.initials: R
authors.lastname: Lazzarini
authors.forename: R
authors.initials: R
authors.lastname: Sorio
authors.forename: F
authors.initials: F
authors.lastname: De Conno
authors.forename: A
authors.initials: A
authors.lastname: Caraceni
mesh_terms: D000208:Acute Disease; D002292:Carcinoma, Renal Cell / Q000628:therapy*; D003244:Consciousness Disorders / Q000139:chemically induced*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009020:Morphine / Q000506:poisoning*; D011994:Recombinant Proteins / Q000009:adverse effects
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins; D009020:Morphine